These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 33455874)
1. I Li S; Guo JH; Lu J; Wang C; Wu H; Wang H; Zha J; Fan R Cancer Radiother; 2021 Jun; 25(4):340-349. PubMed ID: 33455874 [TBL] [Abstract][Full Text] [Related]
2. Endovascular brachytherapy combined with stent placement and TACE for treatment of HCC with main portal vein tumor thrombus. Luo JJ; Zhang ZH; Liu QX; Zhang W; Wang JH; Yan ZP Hepatol Int; 2016 Jan; 10(1):185-95. PubMed ID: 26341514 [TBL] [Abstract][Full Text] [Related]
4. Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus. Zhang ZH; Liu QX; Zhang W; Ma JQ; Wang JH; Luo JJ; Liu LX; Yan ZP World J Gastroenterol; 2017 Nov; 23(43):7735-7745. PubMed ID: 29209114 [TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Irradiation Stent Placement for Malignant Portal Vein Thrombus Combined with Transarterial Chemoembolization for Hepatocellular Carcinoma: A Single-Center Experience. Lu J; Guo JH; Zhu HD; Zhu GY; Chen L; Teng GJ J Vasc Interv Radiol; 2017 Jun; 28(6):786-794.e3. PubMed ID: 28396192 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of endovascular brachytherapy combined with transarterial chemoembolization for the treatment of hepatocellular carcinoma patients with type III or IV portal vein tumor thrombosis. Li L; Cheng N; Huang X; Weng X; Jiao Y; Liu J; Guo W World J Surg Oncol; 2022 Feb; 20(1):30. PubMed ID: 35109883 [TBL] [Abstract][Full Text] [Related]
7. Endovascular brachytherapy combined with portal vein stenting and transarterial chemoembolization improves overall survival of hepatocellular carcinoma patients with main portal vein tumor thrombus. Yu TZ; Zhang W; Liu QX; Li WH; Ma JQ; Zhang ZH; Yang MJ; Wang JH; Chen B; Zeng SC; Luo JJ; Liu LX; Yan ZP Oncotarget; 2017 Feb; 8(7):12108-12119. PubMed ID: 28076848 [TBL] [Abstract][Full Text] [Related]
8. Endovascular placement of iodine-125 seed strand and stent combined with chemoembolization for treatment of hepatocellular carcinoma with tumor thrombus in main portal vein. Luo J; Yan Z; Liu Q; Qu X; Wang J J Vasc Interv Radiol; 2011 Apr; 22(4):479-89. PubMed ID: 21463757 [TBL] [Abstract][Full Text] [Related]
9. Brachytherapy with Iodine-125 seeds for treatment of portal vein-branch tumor thrombus in patients with hepatocellular carcinoma. Hong D; Zhou Y; Wan X; Su H; Shao H BMC Cancer; 2021 Sep; 21(1):1020. PubMed ID: 34521375 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of endovascular implantation of a portal vein stent combined with iodine-125 seed-strips followed by transcatheter arterial chemoembolization with sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis. Li S; Li L; Li B; Wang W Br J Radiol; 2020 Aug; 93(1112):20190279. PubMed ID: 32464068 [TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma with main portal vein tumor thrombus: treatment with 3-dimensional conformal radiotherapy after portal vein stenting and transarterial chemoembolization. Zhang XB; Wang JH; Yan ZP; Qian S; Du SS; Zeng ZC Cancer; 2009 Mar; 115(6):1245-52. PubMed ID: 19156918 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of therapy for hepatocellular carcinoma with portal vein tumor thrombus: chemoembolization and stent combined with iodine-125 seed. Chuan-Xing L; Xu H; Bao-Shan H; Yong L; Pei-Jian S; Xian-Yi Y; Xiao-Ning L; Li-Gong L Cancer Biol Ther; 2011 Nov; 12(10):865-71. PubMed ID: 22037354 [TBL] [Abstract][Full Text] [Related]
13. Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis. Shui Y; Yu W; Ren X; Guo Y; Xu J; Ma T; Zhang B; Wu J; Li Q; Hu Q; Shen L; Bai X; Liang T; Wei Q Radiat Oncol; 2018 Sep; 13(1):188. PubMed ID: 30253783 [TBL] [Abstract][Full Text] [Related]
14. Portal Vein Irradiation Stent Plus Chemoembolization versus External Radiotherapy Plus Chemoembolization in Hepatocellular Carcinoma with Portal Vein Tumour Thrombus: A Retrospective Study. Tan Z; Lu J; Zhu G; Chen L; Wang Y; Zhang Q; Pan T; Wang J; Guo J; Teng G Cardiovasc Intervent Radiol; 2021 Sep; 44(9):1414-1422. PubMed ID: 34131776 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of transarterial chemoembolization combined with lenvatinib, programmed death-1 inhibitor, and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombosis. Lin LW; Yan LY; Ke K; Yang WZ; Lin JQ; Huang N Brachytherapy; 2023; 22(6):858-871. PubMed ID: 37574351 [TBL] [Abstract][Full Text] [Related]
16. Portal Vein Stenting Combined with Iodine-125 Seeds Endovascular Implantation Followed by Transcatheter Arterial Chemoembolization for Treatment of Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus. Sun JH; Zhou T; Zhu T; Zhang Y; Nie C; Ai J; Zhou G; Zhang A; Dong MJ; Wang WL; Zheng SS Biomed Res Int; 2016; 2016():3048261. PubMed ID: 27999793 [TBL] [Abstract][Full Text] [Related]
17. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis]. Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343 [No Abstract] [Full Text] [Related]
18. Portal stent with endovascular brachytherapy improves the efficacy of TACE for hepatocellular carcinoma with main portal vein tumor thrombus. Li T; Liu C; He JT; Sui KD; Zhang ZB; Hong D; Su HY; Shao HB Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):187-190. PubMed ID: 31708399 [No Abstract] [Full Text] [Related]
19. Endovascular implantation of Sun H; Zhang M; Liu R; Liu Y; Hou Y; Wu C Future Oncol; 2018 May; 14(12):1165-1176. PubMed ID: 29334777 [TBL] [Abstract][Full Text] [Related]
20. Irradiation stent with 125 I plus TACE versus sorafenib plus TACE for hepatocellular carcinoma with major portal vein tumor thrombosis: a multicenter randomized trial. Lu J; Guo JH; Ji JS; Li YL; Lv WF; Zhu HD; Sun JH; Ren WX; Zhang FJ; Wang WD; Shao HB; Cao GS; Li HL; Gao K; Yang P; Yin GW; Zhu GY; Wu FZ; Wang WJ; Lu D; Chen SQ; Min J; Zhao Y; Li R; Lu LG; Lau WY; Teng GJ Int J Surg; 2023 May; 109(5):1188-1198. PubMed ID: 37038986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]